MTB and important from FA 4 Flashcards
mcc of CHF
hypertension
All diagnosis of dyspnea except CHF will lack
orthopnea/ paroxysmal nocturnal dyspnea
S3 gallop
the best initial and the most accurate test for Ejection fraction
best initial: Transthoracic echo
most accurate: Multiple-gated acquisition scan (MUGA) (nuclear ventriculography) –> doxorubicin
Transesophangeal as a test (TEE) - accurate at / role in CHF
the most accurate in evaluating heart valve function and diameter
not necessary for evaluating CHF
test used to determine etiology of CHF - endomycoardial biopsy - etiology of CHF
- rarely done
- exclude infiltrative disease such as sarcoid or amyloid when other sites for biopsy inconclusive
- most accurate test for some infections
systolic dysfunction - medication
- ACEi (or receptor blockers)
- Beta blockers
- Spironolactone
- Diuretics
- Digoxin
- Nitrates
- Hydralazine
- Implantable defibralator
- Transplantation
systolic dysfunction - ACEi (or receptor blockers)
ALL patients with systolic dysfunction at any stage of the disease
beneficial effects with ANY drug in the class
systolic dysfunction - beta blockers - which drugs exactly
- Metoprolol (β1)
- Bisoprolol (β2)
- Carvedilol (non-specific beta blocker with also α1 receptor blocking activity)
systolic dysfunction - spironolactone efective?
in NYHA 3 + 4
Devices for CHF treatment
2 other treatments taht are associated with mortality benefit in CHF:
- Implantable defibrillator
- Biventricular pacemaker
CHF - Implantable defibrillator
for those with ischemic cardiomyopathy and EF below 35
CHF - Biventricular pacemaker
- dialted cardiomyopathy and EF less than 35 and a wide QRS above 120 mls who have persistent symptoms
- resychronizes the heart when there is a conduction defect
systolic HF - transplantation
when maximal medical therapy and possible the biventricular pacemaker fail to control symptoms of CHF, then the only alternative is this
systolic CHF - CCB
nor benefits. some can actually raise mortality
Diastolic dysfunction - treatment
- the management here is not as clear as in the systolic
- b-blockers have clear benefits
- digoxin and spironolactone has no benefit and should not used
- diuretics to control symptoms
- unclear benefit for ACEi and ARBs and hydralazine
pulm edema - treatment (preload reduction)
- O2
- Loop diuretics (such as furosemide or bumetanide)
- Morphine
- Nitrates
- Nesiritide can be used as a part of therapy, but it is not clear that it works better than standard agents (and no proven mortality benefit)
pulm edema - treatment (positive inotropic agents)
- Dobutamine when they don’t respond to therapy acutely with preload reduction
- amrinone and milrinone (phosphodiesterase inhibitors) that preform the same role
pulm edema - afterload reduction medication
in acute setting: nitropruside or IV hydralazine
regurgitant disease is most commonly caused by …
- hypertension
- ischemic heart disease
LEADS TO DILATION
valvular heart disease - best initial test (explain)
- best initial: ECHO
- Transesophageal echo is both more sensitive and more specific than transthoracic echo
valvular heart disease - catheterization
most precise measurement of valvular diameter, as well as the exact pressure gradient across the valve
stenotic valvular heart disease - treatment
- diuretics
- mitral stenosis is dilated with a balloon, aortic needs surgical removal
regurgitant valvular heart disease - treatment
- diuretics
- vasodilator therapy with (ACEi, nifedipine, hydralazine)
- surgical replacement before heart dilates
assessment of ventricular size is based on
- the end systolic diameter
2. EF